Development of real world digital health measurements for and by patients that are meaningful to patients and applicable by healthcare providers.

Development of real world digital health measurements for and by patients that are meaningful to patients and applicable by healthcare providers. - MEaNingful DiGitAl Health Measurements for and by patiEnts (ENGAGE)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON57303

Enrollment

Registered

2024-09-25

Start date

2025-10-29

Completion date

Unknown

Last updated

2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Microvascular complications microvascular complications of Diabetes

Interventions

Is een observationele studie met:Dexcom G7 CGMCorsano Cardiowatch&nbsp

McRoberts Movemonitor

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Prediabetic or diagnosed with diabetes type 2; - BMI in the range of 25-35 kg/m2 - Aged in the range of 40 - 65 years - Normal physical activity patterns - Able and willing to sign the informed consent form - Willing to comply with all study procedures

Exclusion criteria

Exclusion criteria: - Type 1 diabetes - Kidney diseases other than related to diabetes - Cardiovascular diseases other than diabetes and/or hypertension related - Skin allergy, eczema or known sensitivity for adhesives

Design outcomes

Primary

Measure	Time frame
The primary outcome measure of this study is the degree of correlation between the parameter patterns, measured by the wearable, and the severity of the micro- and macrovascular damage, as determined by the conventional analyses.	—

Countries

Netherlands

Contacts

Public ContactL. IJsselstijn

Reinier de Graaf

humanstudies@tno.nl0152604503

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026